delorazepam

Small moleculeexperimental

Delorazepam, also known as chlordesmethyldiazepam and nordiclazepam, is a drug which is a benzodiazepine and a derivative of desmethyldiazepam. It is marketed in Italy, where it is available under the trade name EN. Delorazepam is also an active metabolite of the benzodiazepine drugs diclazepam and cloxazolam. — Wikipedia

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2010 (NCT01990755)

Timeline

No events for the selected filters.

Chemistry & pharmacology

Loading structure…

SMILES

O=C1CN=C(c2ccccc2Cl)c2cc(Cl)ccc2N1
Mol. weight
305.16 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 2'-chloronordiazepam
  • 2h-1,4-benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-
  • 7-chloro-5-(2-chlorophenyl) 1,3-dihydro-2h-1,4-benzodiazepin-2-one
  • cddz
  • chlordemethyldiazepam
  • chlordemethyldiazepam
  • chlordesmethyldiazepam
  • chlordesmethyldiazepam
  • chlordesmethyldiazepam
  • chlordesmethyldiazepam
  • chlorodesmethyldiazepam
  • chlorodesmethyldiazepam
  • dadumir
  • dadumir
  • delorazepam
  • delorazepam
  • delorazepam
  • delorazepam
  • delorazepam
  • delorazepam
  • delorazepam
  • delorazepam

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01990755N/AMay 1, 2010University of Milan, University of Turin
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of MilanAcademic/Hospital1012010
University of TurinAcademic/Hospital1112010
2 organizations
Page 1 / 1